EBONI: a tool for automated quantification of bone metastasis load in PSMA PET/CT

J Hammes, P Täger, A Drzezga - Journal of Nuclear Medicine, 2018 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) PET/CT has a high diagnostic accuracy for
lesion detection in metastatic prostate cancer, including bone metastases. Novel therapeutic …

Exploring new multimodal quantitative imaging indices for the assessment of osseous tumor burden in prostate cancer using 68Ga-PSMA PET/CT

M Bieth, M Krönke, R Tauber… - Journal of Nuclear …, 2017 - Soc Nuclear Med
PET combined with CT and prostate-specific membrane antigen (PSMA) ligands has gained
significant interest for staging prostate cancer (PC). In this study, we propose 2 multimodal …

Factors predicting metastatic disease in 68Ga-PSMA-11 PET–positive osseous lesions in prostate cancer

LW Chiu, C Lawhn-Heath, SC Behr… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Bone is the most common site of distant metastatic spread in prostate adenocarcinoma.
Prostate-specific membrane antigen (PSMA) uptake has been described in both benign and …

Bone Uptake in Prostate Cancer Patients: Diagnostic Performances of PSMA-RADS v1. 0, Clinical, Biological, and: 68: Ga-PSMA-11 PET Features to Predict …

A Letang, A Crombé, C Rousseau… - Clinical Nuclear …, 2022 - journals.lww.com
Purpose 68 Gallium-labeled prostate-specific membrane antigen-11 (PSMA) PET/CT is the
new reference to identify relapse during biochemical recurrence of prostate cancer (PCa) …

Do bone scans overstage disease compared with PSMA PET at initial staging? An international multicenter retrospective study with masked independent readers

TA Hope, M Benz, F Jiang, D Thompson… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) PET has a higher accuracy than CT and bone
scans to stage patients with prostate cancer. We do not understand how to apply clinical trial …

68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate …

C Schmidkonz, M Cordes, TI Goetz, O Prante… - Annals of nuclear …, 2019 - Springer
Background To evaluate the role of 68 Gallium prostate-specific membrane antigen-positron
emission tomography/computed tomography (68 Ga-PSMA-11 PET/CT) derived quantitative …

Total-body 68Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer patients: Potential impact on bone scan guidelines

KL Pomykala, J Czernin, TR Grogan… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Our purpose was to determine the relationship between serum prostate-specific antigen
(PSA) level categories (< 5, 5–10, 10–20, and> 20 ng/mL) and the incidence of bone …

68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a …

E Dyrberg, HW Hendel, THV Huynh, TW Klausen… - European …, 2019 - Springer
Objectives To determine the diagnostic accuracy of 68 gallium prostate-specific membrane
antigen (PSMA)-based positron emission tomography/computed tomography (PET/CT) in …

Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer

T Pyka, S Okamoto, M Dahlbender, R Tauber… - European journal of …, 2016 - Springer
Purpose The aim of our study was to compare the diagnostic performance of 68 Ga-PSMA
PET and 99m Tc bone scintigraphy (BS) for the detection of bone metastases in prostate …

Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT

M Caglar, M Tuncel, E Yildiz, E Karabulut - Annals of nuclear medicine, 2020 - Springer
Abstract Objectives Gallium-68-labeled prostate-specific membrane antigen (Ga-PSMA)
positron emission tomography (PET)/computed tomography (CT) is a valuable diagnostic …